Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nutrition, Immunity, and Cancers Publisher



Abolhassani H1, 2 ; Mohammadzadeh Honarvar N3 ; Mosby TT4 ; Mahmoudi M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodefi ciencies, Children’s Medical Center Hospital, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd, Tehran, 14194, Iran
  2. 2. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
  3. 3. School of Nutrition and Dietetics, Tehran University of Medical Sciences, Poursina St, Keshavarz Blvd, Tehran, 14155, Iran
  4. 4. Department of Nutrition, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, United States

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

The immune system is the main defense against invading pathogens, foreign components, and cancerous cells in our body. The inflammatory cascade, including the release of proinflammatory cytokines and formation of free radicals, plays an important role in chronic diseases such as cancer. It is also well understood that nutritional and immunologic influences can occur during initiation, promotion, and progression stages of carcinogenesis. On the other hand, a number of nutritional factors such as energy-protein balance, omega-3 polyunsaturated fatty acids, and antioxidants can modulate gene expression and immune responses. All these factors function differently to modulate our immune response, but all seem to have the potential to protect against cancer development and progression. Other factors such as nutritional support have played a unique role in recovery and reduction of complications from cancer and its treatment. Therefore, establishing, maintaining, supporting, and restoring healthy immune function and proper nutritional status contribute to the prevention and treatment of neoplasms. Because cancer patients face special concerns such as malnutrition and major surgery, they often have impaired host defense mechanisms such as a reduction in neutrophil chemotaxis, phagocytosis, and a loss of monocytes, lymphocytes, and natural killer cells, which increase the morbidity and mortality rates in these cases. In summary, recent findings show that nutrition, immunity, and cancer seem to be locked into a three-way relationship, so immunonutrition may provide a less invasive alternative to immunotherapy against cancers associated with chronic inflammation (Fig. 20.1). © Springer-Verlag Berlin Heidelberg 2015.